| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |